Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Time Posted：2021-03-31 15:32
On the evening of March 30, Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Joincare", 600380.SH) released its 2020 annual report. According to the report, the company achieved operating revenue of 13.522 billion yuan in 2020, a year-on-year increase of 12.87%; net profit attributable to shareholders of the company reached 1.12 billion yuan, a year-on-year increase of 25.28%.
Jiankang Yuan Annual Report: Net profit increased by 25% year-on-year in 2020
Time Posted：2021-03-30 21:50
Jiankangyuan released its annual report, achieving operating revenue of 13.522 billion yuan, a year-on-year increase of 12.87%; net profit of 1.12 billion yuan, a year-on-year increase of 25.28%; basic earnings per share of 0.5753 yuan. It is proposed to distribute a cash dividend of RMB 1.5 per 10 shares (including tax).
Health Yuan inhalation preparation is selected into the new version of COPD guidelines
Time Posted：2021-03-15 13:28
The "Chronic Obstructive Pulmonary Disease Diagnosis and Treatment Guidelines (2021 Revised Edition)" (hereinafter referred to as the "New Guidelines") has been officially released recently. Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan")'s Lisutu (Salbutamol Hydrochloride Inhalation Solution), as the first and only domestically approved short-acting β2-agonist, has been recommended for first-line treatment, marking the official entry of high-standard domestically developed inhalation preparations into the market competition.
Jiankangyuan Group awarded the title of "Shenzhen March 8th Red Banner Collective"
Time Posted：2021-03-09 13:22
On the morning of March 8th, Nanshan District held a themed event at the Nanshan District Women and Children's Activity Center to commemorate the 111th anniversary of International Women's Day and the "Learn Party History, Sing Party Grace, Follow the Party - 100 Women's Tribute to the 100th Anniversary of the Party's Founding." The event shared stories of women, paid tribute to heroic women, and called on women of the new era to continue writing a new chapter in women's undertakings, offering a tribute to the 100th anniversary of the founding of the Communist Party of China.
Time Posted：2021-03-01 10:49
On January 14, 2021, the No. 1 Central Document of 2021, "Opinions of the Central Committee of the Communist Party of China and the State Council on Comprehensively Promoting Rural Revitalization and Accelerating Agricultural and Rural Modernization", was officially released. This is the 18th No. 1 Central Document guiding the work of "agriculture, rural areas, and farmers" since the 21st century. The full text consists of five parts, including: overall requirements; effectively connecting the consolidation and expansion of poverty alleviation achievements with rural revitalization; accelerating agricultural modernization; vigorously implementing rural construction actions; and strengthening the Party's overall leadership over the work of "agriculture, rural areas, and farmers".
Time Posted：2021-02-05 17:47
On February 5, 2021, Beijing Infinite Intelligence Pharma Technology Co., Ltd. announced that it had received Pre-A round investment from Zhuhai Lizhu Pharmaceutical Equity Investment Management Co., Ltd., a wholly-owned investment platform of Lizhu Pharmaceutical (1513.HK, 000513.SZ).
Time Posted：2021-02-03 18:12
On February 1, the Healthy Yuan Research Institute and Tencent Quantum Laboratory signed a strategic cooperation agreement. Both parties will jointly promote the application of quantum computing + artificial intelligence in the research of microbial synthetic biology and related drug research, and promote the development and progress of pharmaceutical research and development technology.
Time Posted：2021-01-22 17:32
The environmental impact report (draft for comments) for the "Jiaozuo Jiankangyuan Biopharmaceutical Co., Ltd. 400-ton annual output of erythromycin thiocyanate pharmaceutical intermediate project" has been basically completed. In accordance with the relevant provisions of the "Public Participation in Environmental Impact Assessment" (Ministry of Ecology and Environment Order No. 4), environmental protection information is now publicly available.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.